Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne

Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) resulted in long-ter...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Casella Francesco, Bencivenga Maria, Rosati Riccardo, Fumagalli Uberto Romario, Marrelli Daniele, Pacelli Fabio, Macrì Antonio, Donini Annibale, Torroni Lorena, Pavarana Michele, De Manzoni Giovanni
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	De Gruyter 2022-06-01
Saila:	Pleura and Peritoneum
Gaiak:	gastric cancer intraperitoneal chemotherapy peritoneal metastases pipac systemic chemotherapy
Sarrera elektronikoa:	https://doi.org/10.1515/pp-2022-0111
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!